SGMO Financial Facts

Collaboration agreements: 2.73M
Research and development: 17.01M
See Full Income Statement

Property and equipment, net: 4.88M
Total current assets: 148.85M
See Full Balance Sheet

Sangamo Biosciences Inc. (SGMO) Earnings

  |   Expand Research on SGMO
Next EPS Date N/A EPS Growth Rate +100.0% *Last Qtr.
Average EPS % Beat Rate -7.5% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS -10.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/6/26 Q425 N/A-$0.01 N/A N/A$33.18M N/A N/A N/A
3/2/26 Q425 N/A-$0.01 N/A N/A$33.18M N/A N/A N/A
2/26/26 Q425 N/A-$0.01 N/A N/A$33.18M N/A N/A N/A
2/25/26 Q425 N/A-$0.01 N/A N/A$33.18M N/A N/A N/A
3/4/26 Q425 N/A-$0.01 N/A N/A$33.18M N/A N/A N/A
11/6/25 Q325 N/A$0.00 N/A N/A$26.4M N/A N/A N/A
8/7/25 Q225 -$0.08-$0.02 -$0.06$18.3M$29.9M N/A Details
5/12/25 Q125 N/A-$0.09 N/A N/A$30.67M N/A N/A N/A